Compulsory licensing of medical patents
The Johnson & Johnson Acuvue Compulsory License
Submitted by Anne Mira Guha on 1. September 2011 - 14:35In April of 2010, District Judge Timothy J. Corrigan (M.D Florida, Jacksonville division) declined to grant a permanent injunction following a finding that the Johnson & Johnson’s ACUVUE®OASYS contact lens product infringed patents owned by CIBA Vision Corporation, providing another example of, in effect, a judicial compulsory license following the 2006 eBay v. MercExchange case; the judge wrote:
The CoreValve compulsory license on patent to treat aortic stenosis
Submitted by James Love on 1. September 2011 - 13:54On February 7, 2011, a federal judge in Delaware rejected a request for an injunction to prevent the continued infringement of United States Patent No.
Statement of the United States to WTO TRIPS Council on the Paragraph 6 System
Submitted by thiru on 4. November 2010 - 0:58The following statement was delivered by USTR at the WTO Council for TRIPS Annual Review of the Paragraph 6 System on Wednesday, 27 October 2010.
Statement of the United States
Agenda item F, Annual Review of the Paragraph 6 System
Topic 5
Agenda item F, Annual Review of the Paragraph 6 System
Topic 5
Mr. Chairman
We are pleased to be here today to participate in the annual review on the implementation of paragraph 6 of the Doha Declaration.
Remarks by UNAIDS Secretariat and on behalf of UNDP: Capacity building on the Paragraph 6 System and related TRIPS flexibilities
Submitted by thiru on 2. November 2010 - 11:50The following statement was delivered on Wednesday, 27 October 2010 by the UNAIDS Secretariat and on behalf of UNDP during the Annual Review of Paragraph 6.
World Trade Organization
Council for TRIPS – Regular Session
Annual Review of Paragraph 6
Doha Declaration on the TRIPS Agreement and Public Health
Agenda item 4 – Capacity building on the Paragraph 6 System and related TRIPS flexibilities
Remarks by UNAIDS Secretariat and on behalf of UNDP
27 October 2010
Mr Chair, Distinguished Delegates
SCP15: KEI statement on Exclusions from Patentable Subject Matter and Exceptions and Limitations to the Rights
Submitted by thiru on 12. October 2010 - 22:00KEI statement on Exclusions from Patentable Subject Matter and Exceptions and Limitations to the Rights
SCP 15
13 October 2010
Thank you Mr. Chair.
We take note of Professor Coenraad Visser's study which examined 'Selected Case Studies of Countries Where Compulsory Licences Have Been Granted for Pharmaceuticals'.
Fabrazyme March-In Request
Submitted by James Love on 2. August 2010 - 12:37New: NIH rejects Fabrazyme March-In Petition
- December 7, 2010. Press release from Fabry patients: DHHS denies patient’s march-in request to end Genzyme’s rationing of treatment for Fabry Disease citing that FDA rules block manufactures from supplying the drug in a timely manner.
- December 7, 2010. Statements by KEI and others on NIH rejection of Fabrazyme March-In Request
Abbott recently sought compulsory license in US patent dispute
Sunday, 29 April 2007
(When the shoe was on the other foot, Abbott asked for a compulsory license, while criticizing Thailand for issuing compulsory licenses)
On the 12th of January 2007, Abbott Laboratories lost a bid in a U.S. District Court (the Western District of Wisconsin) for a compulsory license on a patent held by Innogenetics, Inc. that a judge and jury said Abbott infringed to manufacture and sell Hepatitis C virus (HCV) genotyping test kits.
KEI RN 2007:2 Recent examples of compulsory licensing of patents
KEI Research Note 2007:2 [1]
(A PDF version of this is available here.)
Recent examples of the use of compulsory licenses on patents[1]
KEI Research Note 2007:2
TRIPS Flexibilities and Compulsory Licensing
Submitted by Staff on 24. August 2009 - 11:31Some relevant KEI Research:
- KEI Research Note 2007:2 Recent examples of compulsory licensing of patents.
- KEI work on Patent policy
Compulsory licensing
Submitted by James Love on 4. December 2008 - 9:39This is from an exchange on IP-Health.
———–
Dear Aidan and Thomas.
There are several things I could mention about this revised position on compulsory licenses, but I will begin with these.
